
Gilead Sciences, Inc.
USD130.28
-2.93 (-2.20%)
CEO
Daniel O'Day
IPO Date
1992-01-22
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NASDAQ
Country
US
Open
$131.01
Prev. Close
$133.21
Day Low
$129.13
Day High
$132.87
52W Low
$108.06
52W High
$157.29
Market Cap
$161.75B
Volume
7.45M
| 6 Jul 2026 |
| HSBC |
| Hold |
| Buy |
| upgrade |
| 6 Jul 2026 | Cantor Fitzgerald | Overweight | Overweight | maintain |
| 16 Jun 2026 | Cantor Fitzgerald | Overweight | Overweight | maintain |
| 20 May 2026 | Maxim Group | Hold | Buy | upgrade |
| 8 May 2026 | Truist Securities | Buy | Buy | maintain |
| 8 May 2026 | RBC Capital | Sector Perform | Sector Perform | maintain |
| 13 Apr 2026 | Citigroup | Buy | Buy | maintain |